SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-440278
Filing Date
2013-11-13
Accepted
2013-11-13 16:38:06
Documents
3
Period of Report
2013-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d627902d8k.htm 8-K 15029
2 EX-99.1 d627902dex991.htm EX-99.1 67435
3 GRAPHIC g627902g71q91.jpg GRAPHIC 18308
  Complete submission text file 0001193125-13-440278.txt   108984
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 131215115
SIC: 2834 Pharmaceutical Preparations